These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 17320575)

  • 1. The utility of positron emission tomography in staging of potentially operable carcinoma of the thoracic esophagus: results of the American College of Surgeons Oncology Group Z0060 trial.
    Meyers BF; Downey RJ; Decker PA; Keenan RJ; Siegel BA; Cerfolio RJ; Landreneau RJ; Reed CE; Balfe DM; Dehdashti F; Ballman KV; Rusch VW; Putnam JB;
    J Thorac Cardiovasc Surg; 2007 Mar; 133(3):738-45. PubMed ID: 17320575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The utility of FDG-PET in the preoperative staging of esophageal cancer.
    Gananadha S; Hazebroek EJ; Leibman S; Berry H; Osgood L; Shon IH; Pavlakis N; Marx G; Smith GS
    Dis Esophagus; 2008; 21(5):389-94. PubMed ID: 19125791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The incremental effect of positron emission tomography on diagnostic accuracy in the initial staging of esophageal carcinoma.
    Kato H; Miyazaki T; Nakajima M; Takita J; Kimura H; Faried A; Sohda M; Fukai Y; Masuda N; Fukuchi M; Manda R; Ojima H; Tsukada K; Kuwano H; Oriuchi N; Endo K
    Cancer; 2005 Jan; 103(1):148-56. PubMed ID: 15558794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluorine-18 fluorodeoxyglucose positron emission tomography in the preoperative staging of thoracic oesophageal and gastro-oesophageal junction cancer: a prospective study.
    Katsoulis IE; Wong WL; Mattheou AK; Damani N; Chambers J; Livingstone JI
    Int J Surg; 2007 Dec; 5(6):399-403. PubMed ID: 17631431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The decision to operate: role of integrated computed tomography positron emission tomography in staging oesophageal and oesophagogastric junction cancer by the multidisciplinary team.
    Berrisford RG; Wong WL; Day D; Toy E; Napier M; Mitchell K; Wajed S
    Eur J Cardiothorac Surg; 2008 Jun; 33(6):1112-6. PubMed ID: 18328726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of the introduction of integrated PET-CT into the preoperative staging pathway of patients with potentially operable oesophageal carcinoma.
    Salahudeen HM; Balan A; Naik K; Mirsadraee S; Scarsbrook AF
    Clin Radiol; 2008 Jul; 63(7):765-73. PubMed ID: 18555034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical utility of 18F-fluorodeoxyglucose positron emission tomography/computed tomography in the staging of patients with potentially resectable esophageal cancer.
    You JJ; Wong RK; Darling G; Gulenchyn K; Urbain JL; Evans WK
    J Thorac Oncol; 2013 Dec; 8(12):1563-9. PubMed ID: 24389439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of ¹⁸F-fluorodeoxyglucose positron emission tomography positive lymph nodes on postoperative recurrence and survival in resectable thoracic esophageal squamous cell carcinoma.
    Yasuda T; Higuchi I; Yano M; Miyata H; Yamasaki M; Takiguchi S; Fujiwara Y; Hatazawa J; Doki Y
    Ann Surg Oncol; 2012 Feb; 19(2):652-60. PubMed ID: 21769466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Results of the American College of Surgeons Oncology Group Z0050 trial: the utility of positron emission tomography in staging potentially operable non-small cell lung cancer.
    Reed CE; Harpole DH; Posther KE; Woolson SL; Downey RJ; Meyers BF; Heelan RT; MacApinlac HA; Jung SH; Silvestri GA; Siegel BA; Rusch VW;
    J Thorac Cardiovasc Surg; 2003 Dec; 126(6):1943-51. PubMed ID: 14688710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Whole body 18FDG-PET and the response of esophageal cancer to induction therapy: results of a prospective trial.
    Downey RJ; Akhurst T; Ilson D; Ginsberg R; Bains MS; Gonen M; Koong H; Gollub M; Minsky BD; Zakowski M; Turnbull A; Larson SM; Rusch V
    J Clin Oncol; 2003 Feb; 21(3):428-32. PubMed ID: 12560430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective evaluation of the impact of 18-F-fluoro-deoxy-D-glucose positron emission tomography staging on survival for patients with locally advanced esophageal cancer.
    Blackstock AW; Farmer MR; Lovato J; Mishra G; Melin SA; Oaks T; Aklilu M; Clark PB; Levine EA
    Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):455-60. PubMed ID: 16213103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Staging of esophageal cancer with 18F-fluorodeoxyglucose positron emission tomography.
    Flanagan FL; Dehdashti F; Siegel BA; Trask DD; Sundaresan SR; Patterson GA; Cooper JD
    AJR Am J Roentgenol; 1997 Feb; 168(2):417-24. PubMed ID: 9016218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of positron emission tomography in surgery follow-up of esophageal cancer.
    Teyton P; Metges JP; Atmani A; Jestin-Le Tallec V; Volant A; Visvikis D; Bail JP; Pradier O; Lozac'h P; Cheze Le Rest C
    J Gastrointest Surg; 2009 Mar; 13(3):451-8. PubMed ID: 19023632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymph node analysis in esophageal resection: American College of Surgeons Oncology Group Z0060 trial.
    Veeramachaneni NK; Zoole JB; Decker PA; Putnam JB; Meyers BF;
    Ann Thorac Surg; 2008 Aug; 86(2):418-21; discussion 421. PubMed ID: 18640307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison between positron emission tomography and computed tomography in the use of the assessment of esophageal carcinoma.
    Kato H; Kuwano H; Nakajima M; Miyazaki T; Yoshikawa M; Ojima H; Tsukada K; Oriuchi N; Inoue T; Endo K
    Cancer; 2002 Feb; 94(4):921-8. PubMed ID: 11920459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Positron emission tomography for the preoperative staging of esophageal carcinoma].
    Junginger T; Kneist W; Schreckenberger M; Menzel C; Oberholzer K; Bartenstein P
    Dtsch Med Wochenschr; 2002 Sep; 127(38):1935-41. PubMed ID: 12239652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positron emission tomography with F-18-fluorodeoxyglucose in a combined staging strategy of esophageal cancer prevents unnecessary surgical explorations.
    van Westreenen HL; Heeren PA; van Dullemen HM; van der Jagt EJ; Jager PL; Groen H; Plukker JT
    J Gastrointest Surg; 2005 Jan; 9(1):54-61. PubMed ID: 15623445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes of patients with esophageal cancer staged with [¹⁸F]fluorodeoxyglucose positron emission tomography (FDG-PET): can postchemoradiotherapy FDG-PET predict the utility of resection?
    Monjazeb AM; Riedlinger G; Aklilu M; Geisinger KR; Mishra G; Isom S; Clark P; Levine EA; Blackstock AW
    J Clin Oncol; 2010 Nov; 28(31):4714-21. PubMed ID: 20876421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2-Fluoro-2-deoxy-D-glucose positron emission tomography imaging is predictive of pathologic response and survival after preoperative chemoradiation in patients with esophageal carcinoma.
    Swisher SG; Erasmus J; Maish M; Correa AM; Macapinlac H; Ajani JA; Cox JD; Komaki RR; Hong D; Lee HK; Putnam JB; Rice DC; Smythe WR; Thai L; Vaporciyan AA; Walsh GL; Wu TT; Roth JA
    Cancer; 2004 Oct; 101(8):1776-85. PubMed ID: 15386332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Importance of fluorodeoxyglucose-positron emission tomography (FDG-PET) and endoscopic ultrasonography parameters in predicting survival following surgery for esophageal cancer.
    Omloo JM; Sloof GW; Boellaard R; Hoekstra OS; Jager PL; van Dullemen HM; Fockens P; Plukker JT; van Lanschot JJ
    Endoscopy; 2008 Jun; 40(6):464-71. PubMed ID: 18543134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.